RISK OF ADVERSE EFFECTS When it comes to omega-3 supplementation, the only real downside is if youre taking a poor-quality product
Semaglutide Study Finds Link to Blood Clots A 2021 study published in the Endocrine Journal (Volume 68, Issue 6, pages 739-742) found that type 2 diabetes patients using semaglutide were at a 266% increased risk of deep vein thrombosis
As you lose weight, other weight-related medical issues, such as high blood pressure, begin to decrease, which means reduced chance of heart attacks and overall improved well-being
July 29, 2026 Australia Adds NAION Warnings to GLP-1 Drug Labels Australias drug regulator has added new NAION warnings to the product information for GLP-1 medications, including Ozempic, Wegovy, Mounjaro, Saxenda, and Trulicity